Informed-money record

REGN · REGENERON PHARMACEUTICALS, INC.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

120

Named actors

Disclosed $ (bull / bear)

$276.1M + 1 of unknown size / $59.4M + 1 of unknown size

Recent disclosures

25 of 135 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-10-14	Co-Chief Scientific Officer MURPHY ANDREW J	sold	$218K	SEC ↗
2026-10-14	Co-Chief Scientific Officer MURPHY ANDREW J	sold	$361K	SEC ↗
2026-10-14	Co-Chief Scientific Officer MURPHY ANDREW J	sold	$296K	SEC ↗
2026-10-14	Co-Chief Scientific Officer MURPHY ANDREW J	sold	$30K	SEC ↗
2026-10-14	Co-Chief Scientific Officer MURPHY ANDREW J	sold	$173K	SEC ↗

110 more disclosures in the window — the full record, scoring, and track-record evidence are for members.

Want the read, not just the record?

Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.

Start free — 1 week, no card →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals